Skip to main navigation Skip to search Skip to main content

Abstract

Long-term allergies can exhibit persistent concentrations of circulating immunoglobulin E (IgE). Here, we examined the lifespan of IgE antibody-secreting cells (ASCs) to determine whether the IgE that sustains allergies receives contributions from long-lived cells or relies more heavily on constant ASC production. In mouse aeroallergy, IgE ASCs localized to the lungs, mediastinal lymph nodes, spleen, and bone marrow (BM). IgE ASC production continued for months after allergen exposure ceased. We identified long-lived IgE ASCs residing predominantly outside the BM, with a half-life exceeding 49 days; in contrast, most IgE ASCs had a 3-day half-life. Long-lived IgE ASCs matured phenotypically, became quiescent, retained their surface B cell receptors, but showed low expression of the BM homing receptor CXCR4. They were hierarchically more reliant on the navitoclax-sensitive anti-apoptotic molecules BCL2, BCLXL, and BCLW than MCL1. Thus, continual production of short-lived IgE ASCs and retention of long-lived IgE ASCs outside the BM together drive IgE persistence, perpetuating allergic disease.
Original languageEnglish
Pages (from-to)2704-2716.e4
JournalImmunity
Volume58
Issue number11
DOIs
Publication statusPublished - 11 Nov 2025

Bibliographical note

Publisher Copyright:
© 2025 The Authors

Funding

We thank Rory Markovic and the Monash Animal Research Platform for support with mouse welfare. We thank Melanie Le Page and the ARAFlowcore for flow cytometry support. We thank Philip D. Hodgkin for helpful discussions regarding the modeling. We thank Giovanna Pomilio and Andrew Wei for providing reagents for pilot studies on survival protein reliance. We thank members of the Tarlinton laboratory for input during project development. This work was supported by Australian National Health and Medical Research Council (NHMRC) grants to M.J.R. (APP1185294 and APP2028727) and D.M.T. (APP1175411) ; Monash University FLP fellowships to M.J.R. and Z.D.; a Doctoral Foreign Study Award from the Canadian Institute of Health Research (DFD-170769) to A.K.W.-V.; and the National Heart, Lung, and Blood Institute (DP2HL117752) and National Institute of Allergy and Infectious Diseases (R21AI178523, R21AI178524, and R01AI130470) of the National Institutes of Health grants to C.D.C.A. I.Q. was supported by an NHMRC Peter Doherty Fellowship (APP1145136) . C.D.C.A. also received funding from the Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. The graphical abstract was created in Biorender (Ding Z., 2025; https://BioRender.com /iwznfod) .

FundersFunder number
Australian National Health and Medical Research Council (NHMRC)APP1185294, APP2028727, APP1175411
Monash University FLP fellowships
Canadian Institute of Health ResearchDFD-170769
National Heart, Lung, and Blood InstituteDP2HL117752
National Institute of Allergy and Infectious DiseasesR21AI178523, R21AI178524, R01AI130470
National Institutes of Health
NHMRC Peter Doherty FellowshipAPP1145136
Program for Breakthrough Biomedical Research - Sandler Foundation

    Keywords

    • ABT-263
    • BCL
    • BCL2
    • IgE
    • MCL1
    • allergy
    • antibody-secreting cell
    • apoptosis
    • plasma cell
    • plasmablast

    Fingerprint

    Dive into the research topics of 'Long-lived IgE plasma cells persist in secondary lymphoid tissues using a navitoclax-sensitive survival program'. Together they form a unique fingerprint.

    Cite this